Medifast, Inc. (MED) Tops Q1 EPS by 3c, Revenue Top Expectations
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Join SI Premium – FREE
Medifast, Inc. (NYSE: MED) reported Q1 EPS of $0.44, $0.03 better than the analyst estimate of $0.41. Revenue for the quarter came in at $74.3 million versus the consensus estimate of $73.91 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
